Creates the pharmacy benefit managers quality incentive program. (gov sig) (RE1 SG EX See Note)
Impact
The proposed legislation emphasizes the creation of a structured framework for achieving better healthcare outcomes by rewarding pharmacies that actively engage in improving patient health. PBMs are required to report annually on their incentive programs, detailing their implementations and results. By facilitating this relationship through a quality incentive program, the bill aims to not only promote medication adherence but also potentially lower healthcare costs by reducing emergency visits related to untreated health conditions.
Summary
Senate Bill 171, introduced by Senator Fred Mills, establishes a pharmacy benefit manager (PBM) quality incentive program aimed at improving the health outcomes of Louisiana residents. This program mandates PBMs to develop incentive payment systems for eligible independent pharmacies that comply with health improvement strategies. The focus is on addressing prevalent health issues in Louisiana, such as chronic diseases and medication adherence. The intention is to enhance collaborations between PBMs and local pharmacies, ensuring that patient care and health education become integral components of pharmacy services across the state.
Sentiment
General sentiment around SB 171 leans toward positivity, as it is perceived as a proactive measure in addressing serious health disparities faced by Louisiana residents. Proponents of the bill, including various healthcare advocates, believe it will create better healthcare access and improve community health. Nevertheless, while there appears to be a consensus on the necessity of improving health outcomes, concerns may arise regarding the implementation specifics and the extent to which independent pharmacies would be compelled to participate in the program.
Contention
One notable point of contention lies in the voluntary nature of the incentive program. Although it is framed to encourage participation without penalties for declining, there may be worries regarding whether participation remains truly optional for smaller pharmacies. Additionally, the exemption of Medicaid managed care organization PBMs from the proposed law could lead to disparities in how various entities are regulated under the new system, prompting questions about fairness in health resource distribution and access across Louisiana's diverse healthcare landscape.
Urges the attorney general and the Louisiana Department of Insurance to investigate pharmacy benefit managers (PBMs) for potential violations of law and to urge and request the legislature to pass legislation prohibiting PBMs from owning or having a financial interest in pharmacies in this state